Search by Drug Name or NDC
NDC 76420-0202-90 Clindamycin hydrochloride 300 mg/1 Details
Clindamycin hydrochloride 300 mg/1
Clindamycin hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Asclemed USA, Inc.. The primary component is CLINDAMYCIN HYDROCHLORIDE.
Product Information
| NDC | 76420-0202 |
|---|---|
| Product ID | 76420-202_fab215a4-0e6e-767a-e053-6294a90a89ed |
| Associated GPIs | |
| GCN Sequence Number | 009340 |
| GCN Sequence Number Description | clindamycin HCl CAPSULE 300 MG ORAL |
| HIC3 | W1K |
| HIC3 Description | LINCOSAMIDE ANTIBIOTICS |
| GCN | 40832 |
| HICL Sequence Number | 004044 |
| HICL Sequence Number Description | CLINDAMYCIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | Clindamycin hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clindamycin hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLINDAMYCIN HYDROCHLORIDE |
| Labeler Name | Asclemed USA, Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065061 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76420-0202-90 (76420020290)
| NDC Package Code | 76420-202-90 |
|---|---|
| Billing NDC | 76420020290 |
| Package | 90 CAPSULE in 1 BOTTLE (76420-202-90) |
| Marketing Start Date | 2023-05-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |